IRCT138711221674N1
Completed
Phase 2
A Clinical trial of paracetamole administration after maxillofacial surgery in Post-operative opioid requirements.
Vice chancellor for research, Shiraz University of Medical Sciences0 sites100 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Maxillofacial Surgery( correction after injury).
- Sponsor
- Vice chancellor for research, Shiraz University of Medical Sciences
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion Criteria: 15 to 45\-year\-old patients; and class I patients (ASA)
- •Exclusion criteria: The patients out of age range of 15 to 45 years; patients other than class I (ASA)
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Paracetamol in febrile neutropenia feasibility studyACTRN12613000601730Malaghan Institute of Medical Research37
Not yet recruiting
Phase 4
paracetamol versus ibuprofen in the management of patent ductus arteriosus (congenital heart disease) in preterm infantsHealth Condition 1: Q250- Patent ductus arteriosusHealth Condition 2: null- preterm infants with patent ductus arteriosusHealth Condition 3: P073- Preterm [premature] newborn [other]CTRI/2018/02/011942Hinal A Sinol
Recruiting
Phase 3
Efficacy of paracetamol for pain reductioIRCT20181001041196N1Shahid Beheshti University of Medical Sciences60
Completed
Not Applicable
The PaPa Trial: Paracetamol as an adjunct to intraPartum Remifentanil/PCA. An RCT of multimodal pain management during labor.abour painNL-OMON24756ot applicable80
Active, not recruiting
Phase 1
Study to investigate the behaviour of paracetamol in the body of patients over 80 years old admitted to an acute geriatric wardEUCTR2015-004217-24-BEZ Leuven